ID   Mes-9
AC   CVCL_H658
SY   MM 1-53; 1-53
DR   Wikidata; Q54905244
RX   PubMed=7479897;
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Unexplicit; 43-bp insertion at junction of exons 13/14; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
RX   PubMed=7479897; DOI=10.1073/pnas.92.24.10854; PMCID=PMC40529;
RA   Bianchi A.B., Mitsunaga S.-i., Cheng J.-Q., Klein W.M., Jhanwar S.C.,
RA   Seizinger B.R., Kley N., Klein-Szanto A.J.P., Testa J.R.;
RT   "High frequency of inactivating mutations in the neurofibromatosis
RT   type 2 gene (NF2) in primary malignant mesotheliomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10854-10858(1995).
//
RX   PubMed=10451704; DOI=10.1002/(SICI)1098-2264(199903)24:3<238::AID-GCC9>3.0.CO;2-M;
RA   Cheng J.-Q., Lee W.-C., Klein M.A., Cheng G.Z., Jhanwar S.C.,
RA   Testa J.R.;
RT   "Frequent mutations of NF2 and allelic loss from chromosome band 22q12
RT   in malignant mesothelioma: evidence for a two-hit mechanism of NF2
RT   inactivation.";
RL   Genes Chromosomes Cancer 24:238-242(1999).
//